Literature DB >> 24064227

The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood.

Ville Kytö1, Jussi Sipilä, Päivä Rautava.   

Abstract

OBJECTIVE: To study the effects of gender and age on occurrence of myocarditis.
DESIGN: Nationwide, multicentre registry study in Finland.
SETTING: All medical hospital admissions (n=1 698 397) of patients aged ≥ 16 years during 9.5 years in 29 hospitals. PATIENTS: 3198 myocarditis patients.
RESULTS: Myocarditis was more common in men (76.61%; 95% CI 75.11% to 78.05%) than in women (23.39%; 95% CI 21.95% to 24.89%, p<0.0001). Median age of patients was 33 years (IQR 23-50 years). Male patients were significantly younger than females (mean age 34.1 ± SD 15.1 vs 49.0 ± 18.7 years, p<0.0001). In men, occurrence was highest at 16-20 yrs of age, with a linear decline to elderliness (r=-0.95, p<0.0001). By contrast, myocarditis affected women more evenly at all ages with highest occurrence at the age of 56-60 years. Myocarditis caused 0.19% (95% CI 0.18% to 0.19%) of all medical admissions, and 0.48% (95% CI 0.46% to 0.49%) of admissions due to cardiovascular reasons with an inverse logarithmic association with age (r=-0.97, p<0.0001). Admissions were more commonly caused by myocarditis in men (risk ratio 3.11; 95% CI 2.87 to 3.38, p<0.0001).
CONCLUSIONS: Men are significantly more susceptible to myocarditis than women. Young men are especially at risk for acquiring myocarditis, while women are affected most commonly at the postmenopausal age. The proportion of hospital admissions caused by myocarditis has an inverse, logarithmic association with age.

Entities:  

Mesh:

Year:  2013        PMID: 24064227     DOI: 10.1136/heartjnl-2013-304449

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  27 in total

Review 1.  ST-Segment Elevation Myocardial Infarction: Sex Differences in Incidence, Etiology, Treatment, and Outcomes.

Authors:  Tayyab Shah; Sohum Kapadia; Alexandra J Lansky; Cindy L Grines
Journal:  Curr Cardiol Rep       Date:  2022-03-14       Impact factor: 2.931

2.  Biological Sex and Its Impact on Clinical Characteristics in Patients Presenting with Myocarditis.

Authors:  Moritz Mirna; Lukas Schmutzler; Albert Topf; Uta C Hoppe; Michael Lichtenauer
Journal:  Med Princ Pract       Date:  2021-11-11       Impact factor: 1.927

3.  Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy.

Authors:  Stephane Heymans; James S Ware; Sanjay K Prasad; Amrit S Lota; Mark R Hazebroek; Pantazis Theotokis; Rebecca Wassall; Sara Salmi; Brian P Halliday; Upasana Tayal; Job Verdonschot; Devendra Meena; Ruth Owen; Antonio de Marvao; Alma Iacob; Momina Yazdani; Daniel J Hammersley; Richard E Jones; Riccardo Wage; Rachel Buchan; Fredrik Vivian; Yakeen Hafouda; Michela Noseda; John Gregson; Tarun Mittal; Joyce Wong; Jan Lukas Robertus; A John Baksi; Vassilios Vassiliou; Ioanna Tzoulaki; Antonis Pantazis; John G F Cleland; Paul J R Barton; Stuart A Cook; Dudley J Pennell; Pablo Garcia-Pavia; Leslie T Cooper
Journal:  Circulation       Date:  2022-09-26       Impact factor: 39.918

4.  Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines.

Authors:  Stéphane Le Vu; Marion Bertrand; Marie-Joelle Jabagi; Jérémie Botton; Jérôme Drouin; Bérangère Baricault; Alain Weill; Rosemary Dray-Spira; Mahmoud Zureik
Journal:  Nat Commun       Date:  2022-06-25       Impact factor: 17.694

Review 5.  Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.

Authors:  Jennifer Pillay; Lindsay Gaudet; Aireen Wingert; Liza Bialy; Andrew S Mackie; D Ian Paterson; Lisa Hartling
Journal:  BMJ       Date:  2022-07-13

6.  Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.

Authors:  Matthew E Oster; David K Shay; John R Su; Julianne Gee; C Buddy Creech; Karen R Broder; Kathryn Edwards; Jonathan H Soslow; Jeffrey M Dendy; Elizabeth Schlaudecker; Sean M Lang; Elizabeth D Barnett; Frederick L Ruberg; Michael J Smith; M Jay Campbell; Renato D Lopes; Laurence S Sperling; Jane A Baumblatt; Deborah L Thompson; Paige L Marquez; Penelope Strid; Jared Woo; River Pugsley; Sarah Reagan-Steiner; Frank DeStefano; Tom T Shimabukuro
Journal:  JAMA       Date:  2022-01-25       Impact factor: 157.335

7.  Acute myocardial infarction or acute myocarditis? Discharge registry-based study of likelihood and associated features in hospitalised patients.

Authors:  Ville Kytö; Jussi Sipilä; Päivi Rautava
Journal:  BMJ Open       Date:  2015-05-25       Impact factor: 2.692

8.  Likelihood and predictors of ST-elevation in patients hospitalized for myocardial infarction.

Authors:  Ville Kytö; Jussi Sipilä; Päivi Rautava
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

Review 9.  T-cell immunity in myocardial inflammation: pathogenic role and therapeutic manipulation.

Authors:  E Stephenson; K Savvatis; S A Mohiddin; F M Marelli-Berg
Journal:  Br J Pharmacol       Date:  2016-10-04       Impact factor: 8.739

10.  Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017.

Authors:  Xiqiang Wang; Xiang Bu; Linyan Wei; Jing Liu; Dandan Yang; Douglas L Mann; Aiqun Ma; Tomohiro Hayashi
Journal:  Front Cardiovasc Med       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.